TransMedics Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
TransMedics Group (TMDX) Misses Q2 EPS by 11c
August 5, 2021 4:42 PM EDTTransMedics Group (NASDAQ: TMDX) reported Q2 EPS of ($0.39), $0.11 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.8 million.
Cash, cash equivalents and marketable securities were $112.2 million as of June 30, 2021.
For earnings history and... More
